iCBT With TMS in Patients With MDD
Sponsored by University of California, Los Angeles
About this trial
Last updated 2 years ago
Study ID
19000581
Status
Recruiting
Type
Interventional
Phase
N/A
Placebo
No
Accepting
18+ Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended a year ago
What is this trial about?
Major Depressive Disorder (MDD) is a common mental health diagnosis. While there are many
approaches to the treatment of MDD, current treatments of MDD often do not substantially
reduce depressive symptoms among those in need of care. Prior research suggests that
combining cognitive-behavioral therapy (CBT) and psychopharmacology can produce optimal
treatment outcomes compared to the use of either treatment individually. Transcranial
Magnetic Stimulation (TMS) is one promising brain stimulation approach used to treat MDD,
especially among patients with treatment-resistant symptoms. Like psychopharmacological
interventions, TMS may produce optimal treatment outcomes when paired with CBT. However,
standard TMS protocols are time-intensive, typically requiring daily doctor visits for one
hour of six to eight weeks. Therefore, an internet-delivered CBT protocol may augment the
effects of TMS without substantially increasing patient burden. To that end, the present
study assesses if a combined TMS and internet-delivered CBT protocol may produce superior
treatment outcomes compared with TMS alone.
What are the participation requirements?
Inclusion Criteria
Locations
Location
Status
Recruiting